|
Maternal age at laser therapy (year-old)
|
33.2 ± 5.1
|
31.4 ± 4.2
|
0.077*
|
|
Gestational age at operation (weeks)
|
20.7 ± 2.9
|
20.8 ± 2.6
|
0.89*
|
|
Amniotic fluid maximum vertical pocket (cm) of recipient twin
|
12.0 [6]
|
10.8 [3.69]
|
0.51#
|
|
Gestational age at delivery (weeks)
|
34.0 [6.0]
|
34.4 [5.1]
|
0.93#
|
|
Birth weight of liveborn recipients(g)
|
2180 [1312]
|
2010 [775]
|
0.97#
|
|
Birth weight of liveborn donors (g)
|
1955 [1330]
|
1635 [865]
|
0.20#
|
|
Severe Quintero stage (stage III and IV TTTS)
|
66.6% (16/24)
|
42.4% (50/118)
|
0.030※
|
|
Interval form laser therapy to delivery (days)
|
88 [57]
|
9 [40]
|
0.51#
|
|
Intertwin EFWD (%)
|
17.4 ± 12.8
|
24.7 ± 16.9
|
0.046*
|
|
Intertwin BWD (%)
|
− 0.6 [16.2] (n = 15)
|
16.5 [21.5] (n = 71)
|
< 0.001#
|
|
Donor survival
|
79.2% (19/24)
|
68.6% (81/118)
|
0.34※
|
|
Recipient survival
|
75.0% (18/24)
|
78.8% (93/118)
|
0.79※
|
|
Two fetuses survival rate
|
62.5% (15/24)
|
60.2% (71/118)
|
0.82※
|
|
Total survival
|
77.1% (37/48)
|
72.9% (172/236)
|
0.60※
|
